logoTry Persana

Ginkgo Bioworks, Inc. - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Ginkgo Bioworks, Inc. including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Ginkgo Bioworks, Inc. company logo

Making biology easier to engineer.

Ginkgo Bioworks, Inc. is a synthetic biology company specializing in cell programming to create customized organisms for a variety of applications.

HeadquartersBoston, Massachusetts, United States
Team size501-1000
Founded2009

What is Ginkgo Bioworks, Inc.? - Company Overview & Details

Ginkgo Bioworks, Inc. is Ginkgo Bioworks, Inc. is a synthetic biology company specializing in cell programming to create customized organisms for a variety of applications. Founded in 2009, the company is headquartered in Boston, Massachusetts, United States.

Who Founded Ginkgo Bioworks, Inc.?

Ginkgo Bioworks, Inc. was founded by Barry Canton.

Who are the Key Executives at Ginkgo Bioworks, Inc.? - Leadership Team

Ginkgo Bioworks, Inc. is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Ginkgo Bioworks, Inc.

Mat FalkowskiCEO

Chief Technology Officer (CTO) of Ginkgo Bioworks, Inc.

Barry CantonCTO

About Mat Falkowski - CEO of Ginkgo Bioworks, Inc.

Mat Falkowski serves as the Chief Executive Officer of Ginkgo Bioworks, Inc., leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Ginkgo Bioworks, Inc. Company Details & Key Information

Where is Ginkgo Bioworks, Inc. located?

Ginkgo Bioworks, Inc. is headquartered in Boston, Massachusetts, United States.

How many employees does Ginkgo Bioworks, Inc. have?

Ginkgo Bioworks, Inc. has 501-1000 employees.

When was Ginkgo Bioworks, Inc. founded?

Ginkgo Bioworks, Inc. was founded in 2009.

Ginkgo Bioworks, Inc. Official Website

How much funding has Ginkgo Bioworks, Inc. raised?

Ginkgo Bioworks, Inc. has raised undisclosed amount across 18 funding rounds. The most recent funding was completed on 2024-05-10.

Funding Overview

Ginkgo Bioworks has engaged in various funding rounds, primarily involving grants.

N/A
Total Funding Raised
18
Funding Rounds
2024-05-10
Latest Round

Ginkgo Bioworks, Inc. Funding History

Grant
2024-05-10

Who are the key investors in Ginkgo Bioworks, Inc.?

Ginkgo Bioworks, Inc. is backed by 1 key investors including Bill & Melinda Gates Foundation. These investors focus on Global health, Education sectors.

Ginkgo Bioworks, Inc. Investor Overview

1
Key Investors
2
Focus Areas
0
Notable Investments

Complete List of Ginkgo Bioworks, Inc. Investors

Bill & Melinda Gates Foundation

A philanthropic foundation that supports global health and education initiatives.

Investment Focus
Global health
Education

What sectors do Ginkgo Bioworks, Inc. investors focus on?

The investors backing Ginkgo Bioworks, Inc. primarily focus on Global health, Education sectors.

Global health
Education

Featured Investor: Bill & Melinda Gates Foundation

Bill & Melinda Gates Foundation

A philanthropic foundation that supports global health and education initiatives.

Notable Investments:

What are Ginkgo Bioworks, Inc.'s future plans?

Ginkgo Bioworks, Inc. Focus on expanding funding and partnerships for innovative biomanufacturing solutions.

Ginkgo Bioworks, Inc. Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Ginkgo Bioworks, Inc. face?

Ginkgo Bioworks, Inc. has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Ginkgo Bioworks, Inc.

1

Competition in biotechnology sector

2

Regulatory hurdles

What opportunities does Ginkgo Bioworks, Inc. have?

Ginkgo Bioworks, Inc. has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Ginkgo Bioworks, Inc.

1

Expanding into new pharmaceutical areas

2

Partnerships for innovation in biosafety

Ginkgo Bioworks, Inc. Strategic Position Summary

Key Focus Areas

Ginkgo Bioworks, Inc. is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Ginkgo Bioworks, Inc.?

Ginkgo Bioworks, Inc. has 2 recent news updates covering key business developments and market activities.

Ginkgo Bioworks, Inc. News Overview

2
Recent Articles
Active
Media Coverage
2025-04-10
Latest Update

What is Ginkgo Bioworks, Inc. in the news for?

Ginkgo Bioworks, Inc. is currently featured in news for Ginkgo Bioworks, Inc. is developing affordable cell-free biological processes. and other significant business developments.

Recent News Articles About Ginkgo Bioworks, Inc.

Article 1
2025-04-10

Ginkgo Bioworks, Inc. is developing affordable cell-free biological processes.

Ginkgo Bioworks gains a $29 million contract by ARPA-H to develop distributed manufacturing of essential medicines.

contractpharma.com
Read News
Article 2
2025-02-27

Ginkgo Bioworks, Inc. will expand offices to Boston, Massachusetts, United States on Nov 1st '25.

Ginkgo Bioworks is scaling back its Seaport real estate and subleasing excess lab space.

bostonglobe.com
Read News

Ginkgo Bioworks, Inc. FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Ginkgo Bioworks, Inc. including information about founders, CEO, funding history, investors, headquarters location, and company details. 17 frequently asked questions covering key information about the company.

Ginkgo Bioworks, Inc. Questions & Answers - Company Information

Q1

What is Ginkgo Bioworks, Inc.?

Ginkgo Bioworks, Inc. is a synthetic biology company specializing in cell programming to create customized organisms for a variety of applications.

Q2

Who founded Ginkgo Bioworks, Inc.?

Ginkgo Bioworks, Inc. was founded by Barry Canton.

Q3

Who is the CEO of Ginkgo Bioworks, Inc.?

The CEO of Ginkgo Bioworks, Inc. is Mat Falkowski. You can find more information about them on their LinkedIn profile.

Q4

Who are the investors in Ginkgo Bioworks, Inc.?

Ginkgo Bioworks, Inc.'s key investors include Bill & Melinda Gates Foundation.

Q5

Where is Ginkgo Bioworks, Inc. headquartered?

Ginkgo Bioworks, Inc. is headquartered in Boston, Massachusetts, United States.

Q6

When was Ginkgo Bioworks, Inc. founded?

Ginkgo Bioworks, Inc. was founded in 2009.

Q7

How many employees does Ginkgo Bioworks, Inc. have?

Ginkgo Bioworks, Inc. has 501-1000 employees.

Q8

What is Ginkgo Bioworks, Inc.'s official website?

You can visit Ginkgo Bioworks, Inc.'s official website at https://www.ginkgo.bio/.

Q9

What was Ginkgo Bioworks, Inc.'s latest funding round?

Ginkgo Bioworks, Inc.'s latest funding round was a Grant round completed on 2024-05-10.

Q10

Who is founder?

Mat Falkowski

Q11

Who is cto?

Barry Canton

Q12

What does the company do?

Ginkgo Bioworks, Inc. is a synthetic biology company specializing in cell programming to create customized organisms for a variety of applications.

Q13

Latest funding date?

2024-05-10

Q14

Who are the investors?

Bill & Melinda Gates Foundation

Q15

What are the challenges?

Competition in biotechnology sector Regulatory hurdles

Q16

What are the opportunities?

Expanding into new pharmaceutical areas Partnerships for innovation in biosafety

Q17

Latest news?

Ginkgo Bioworks gains a $29 million contract by ARPA-H to develop distributed manufacturing of essential medicines. Ginkgo Bioworks is scaling back its Seaport real estate and subleasing excess lab space.

More Information About Ginkgo Bioworks, Inc.

For additional details about Ginkgo Bioworks, Inc., including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.